Trademark: 79176421
Status Date
Thursday, January 4, 2024
Registration Number
5202108
Registration Date
Tuesday, May 16, 2017
Filing Date
Monday, August 24, 2015
Published for Opposition
Tuesday, February 28, 2017
9 Computer software for diagnosis of disease; Computer software for diagnosing of cancer diseases; Computer software for diagnosing of pancreatic cancer; Computer software for diagnosing of breast cancer; Computer software for diagnosing of prostate cancer; Computer software for diagnosing of auto-immune diseases; DNA chips
5 Sanitary preparations for medical use; biological indicators for medical diagnosis; diagnostic preparations for medical purposes; diagnostic reagents for medical use; chemical reagents for medical purposes for the diagnosis of cancer and auto-immune diseases
44 Performing diagnosis of diseases; medical services for the diagnosis of conditions of the human body; performing diagnosis of cancer and auto-immune diseases
10 Medical apparatus and instruments for diagnostic, prognostic patient stratification, examination and monitoring purposes, namely, apparatus for multiplex measuring of proteins in blood; diagnostic apparatus for medical purposes for diagnosing cancer and auto-immune diseases; sensor apparatus for medical use in diagnosis for diagnosing cancer and auto-immune diseases; apparatus for carrying-out diagnostic tests for medical purposes for diagnosing cancer and auto-immune diseases; medical diagnostic apparatus for detecting cancer and auto-immune diseases; DNA microarray for use in medical research for medical purposes for the diagnosis of cancer and auto-immune diseases; blood testing analyzers for medical purposes for the diagnosis of cancer and auto-immune diseases
42 Medical research services; scientific research for medical purposes in the area of cancerous diseases; scientific research for medical purposes in the area of pancreatic cancerous diseases; scientific research for medical purposes in the area of breast cancerous diseases; scientific research for medical purposes in the area of prostate cancerous diseases; scientific research for medical purposes in the area of auto-immune diseases; providing computer aided medical testing services, namely, computer aided blood analysis services in the field of cancer and auto-immune diseases research; research and development of computer software
Jan 4, 2024
Notice Of Acceptance Of Sec. 71 - E-Mailed
Jan 4, 2024
Registered-Sec.71 Accepted
Jan 3, 2024
Case Assigned To Post Registration Paralegal
May 4, 2023
Teas Section 71 Received
May 16, 2022
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Sep 29, 2017
Final Decision Transaction Processed By Ib
Aug 17, 2017
Final Disposition Notice Sent To Ib
Aug 17, 2017
Final Disposition Processed
Aug 16, 2017
Final Disposition Notice Created, To Be Sent To Ib
May 16, 2017
Registered-Principal Register
May 5, 2017
Notification Of Possible Opposition - Processed By Ib
Apr 19, 2017
Notification Of Possible Opposition Sent To Ib
Apr 19, 2017
Notification Of Possible Opposition Created, To Be Sent To Ib
Feb 28, 2017
Official Gazette Publication Confirmation E-Mailed
Feb 28, 2017
Published For Opposition
Feb 24, 2017
Notification Processed By Ib
Feb 8, 2017
Notification Of Possible Opposition Sent To Ib
Feb 8, 2017
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 8, 2017
Notification Of Notice Of Publication E-Mailed
Jan 24, 2017
Law Office Publication Review Completed
Jan 16, 2017
Approved For Pub - Principal Register
Jan 16, 2017
Examiner's Amendment Entered
Jan 16, 2017
Notification Of Examiners Amendment E-Mailed
Jan 16, 2017
Examiners Amendment E-Mailed
Jan 16, 2017
Examiners Amendment -Written
Jul 19, 2016
Notification Of Final Refusal Emailed
Jul 19, 2016
Final Refusal E-Mailed
Jul 19, 2016
Final Refusal Written
Jun 28, 2016
Preliminary/Voluntary Amendment - Entered
Jun 28, 2016
Teas Voluntary Amendment Received
Jun 20, 2016
Teas/Email Correspondence Entered
Jun 20, 2016
Correspondence Received In Law Office
Jun 18, 2016
Assigned To Lie
Jun 10, 2016
Teas Response To Office Action Received
Jan 4, 2016
Refusal Processed By Ib
Dec 11, 2015
Non-Final Action Mailed - Refusal Sent To Ib
Dec 10, 2015
Refusal Processed By Mpu
Dec 9, 2015
Non-Final Action (Ib Refusal) Prepared For Review
Dec 8, 2015
Non-Final Action Written
Dec 8, 2015
Assigned To Examiner
Nov 25, 2015
Application Filing Receipt Mailed
Nov 21, 2015
New Application Office Supplied Data Entered
Nov 19, 2015
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
